KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?

Figure 4

Expression of BRAF V600E in area of hyperplasia contiguous to BRAF mutated cancer, with absence of staining in normal mucosae ×50, 100 HPF.